Covid-19: mise à jour des stratégies thérapeutiques curatives précoces et du patient sous oxygénothérapie

K Jaffal, B Davido - Revue des Maladies Respiratoires, 2023 - Elsevier
Résumé Introduction Il existe désormais dans la prise en charge du COVID-19 des
traitements préventifs mais également curatifs à la phase précoce et avancée de la maladie …

Mise au point concernant les traitements curatifs et préventifs dans la Covid-19

K Jaffal, B Davido - La Presse Médicale Formation, 2023 - Elsevier
Points essentiels Les mesures barrières (gestes et vaccination) constituent un axe majeur
de la prévention individuelle et collective contre la Covid-19. Les antibiotiques n'ont pas leur …

Traitements contre la COVID-19: orientations évolutives, 20 novembre 2020

O mondiale de la Santé - 2020 - JSTOR
Pratique en vigueur: La pratique actuellement suivie pour traiter la COVID-19 est variable,
ce qui témoigne d'un degré d'incertitude élevé. De nombreux essais contrôlés randomisés …

[HTML][HTML] Experience in the use of remdesivir in patients with SARS-CoV-2 pneumonia

A Murgadella-Sancho, B Gracia-García… - Farmacia …, 2021 - Elsevier
Objective To describe the effectiveness and safety of remdesivir in patients with SARS-CoV-
2 pneumonia in real-world clinical practice conditions. Method Retrospective observational …

Remdesivir for patients with Coronavirus disease 2019 pneumonia requiring high oxygen support

RS Alibrahim, EZ Elmekaty, MZI Elmekaty… - Qatar Medical …, 2022 - qscience.com
Background: Treatment options for patients with critical Coronavirus Disease 2019 (COVID-
19) are limited. This study aimed to describe the clinical characteristics and outcomes …

The use of remdesivir for the management of patients with moderate-to-severe COVID-19: a systematic review

K Thiruchelvam, CS Kow, MA Hadi… - Expert review of anti …, 2022 - Taylor & Francis
Objective We systematically reviewed the evidence of published original research to
determine the role of remdesivir in the management of patients with COVID-19 and a …

Early post-exposure and curative therapeutic strategies against COVID-19

K Jaffal, B Davido - Revue des maladies respiratoires, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction There now exist preventive and curative treatments available for both early and
advanced stages of COVID-19 management. Current knowledge Antibiotics have no place …

[HTML][HTML] Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3 …

F Ader, M Bouscambert-Duchamp, M Hites… - The Lancet infectious …, 2022 - thelancet.com
Background The antiviral efficacy of remdesivir against SARS-CoV-2 is still controversial.
We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with …

Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

F Ader, M Bouscambert-Duchamp, M Hites… - medRxiv, 2022 - medrxiv.org
Background The antiviral efficacy of remdesivir is still controversial. We aimed at evaluating
its clinical effectiveness in hospitalised patients with COVID-19, with indication of oxygen …

Experiencia de utilización de remdesivir en pacientes con neumonía por SARS-CoV-2

A Murgadella-Sancho, B Gracia-García… - Farmacia …, 2021 - SciELO Espana
MURGADELLA-SANCHO, Anna et al. Experience in the use of remdesivir in patients with
SARS-CoV-2 pneumonia. Farm Hosp.[online]. 2021, vol. 45, n. 5, pp. 253-257. Epub 16-Ene …